Onco360 and
ZERO Prostate Cancer

Onco360 and ZERO Prostate Cancer Share a Common Goal – to Improve the Lives of Men and Families Impacted by Prostate Cancer

A prostate cancer diagnosis can be overwhelming, but no one has to face it alone. That’s why, for the second year in a row, we’ve donated to ZERO’s MENtor Program and helped provide more than 750 prostate cancer patients peer-to-peer support,
mentorship, guidance, and support.

 

How We Help Prostate Cancer Patients

Currently, our prostate cancer patients’
average copay is $11

Last year, Onco360 sourced almost
$102 million in third-party funding
for our prostate cancer patients

97% of our prostate cancer patients
paid less than $25 for their last dispense

Onco360 Dispenses These Prostate Cancer and Urology Medications*

Abiraterone Acetate
Akeega® (niraparib and abiraterone acetate)
Casodex® (bicalutamide)
Erleada® (apalutamide)
Firmagon® (degarelix)
Jevtana® (cabazitaxel)
Keytruda® (pembrolizumab)
Lupron® (leuprolide)
Nilandron® (nilutamide)
Novantrone® (mitoxantrone)
Nubeqa® (darolutamide)
Orgovyx® (relugolix)

Paraplatin® (carboplatin)
Platinol® (cisplatin)
Talzenna® (talazoparib)
Taxotere® (doxetaxel)
Toposar® (etoposide)
Trelstar® (triptorelin)
Xgeva® (denosumab)
Xtandi® (enzalutamide)
Yonsa® (abiraterone acetate, micronized)
Zoladex® (goserelin)
Zometa® (zoledronic acid)
Zytiga® (abiraterone acetate)

*This list is a small portion of the comprehensive medications Onco360 can provide.

Care and Connection that Make a Difference

Together, Onco360 and ZERO Prostate Cancer provide the clinical care and community support patients need to feel confident throughout their journey. Whether you’re a patient seeking help or a provider looking for a trusted pharmacy partner, we’re here every step of the way.